You are here

Recombinant Silk Elastin-like Protein Polymers for the Embolization of Cerebral Aneurysms

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41NS100184-01A1
Agency Tracking Number: R41NS100184
Amount: $400,000.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: 106
Solicitation Number: PA16-303
Timeline
Solicitation Year: 2016
Award Year: 2017
Award Start Date (Proposal Award Date): 2017-08-15
Award End Date (Contract End Date): 2020-01-31
Small Business Information
324 S STATE ST STE 221
Salt Lake City, UT 84111-5226
United States
DUNS: 828787379
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 HAMID GHANDEHARI
 (801) 587-1566
 hamid.ghandehari@pharm.utah.edu
Business Contact
 DARWIN CHENEY
Phone: (801) 587-1514
Email: dcheney@theratarget.com
Research Institution
 UNIVERSITY OF UTAH
 
75 SOUTH 2000 EAST
SALT LAKE CITY, UT 84112-8930
United States

 Nonprofit College or University
Abstract

NARRATIVE
This STTR Phase I proposal details the rationale and the research plan for the development of a novel liquid
embolizing agent composed of the genetically engineered protein polymerSELPsilk elastinlike
proteinKto embolize cerebral aneurysmsThe SELP embolic would reduce the risk of aneurysm
rupture while minimizing the risk of recanalization after treatment and providing a platform for delivering
newly developed drugs or cell therapies directly to the aneurysmal sacThis work will result in an embolic that
can potentially improve aneurysm healingdeliver therapeutics locallyand reduce the risks associated with the
embolization of cerebral arteries

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government